Tore Saxne

Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum

Tore Saxne, Maria Angela Palladino, Dick Heinegård et al. · Arthritis & Rheumatism · 1988 · 566 citations

Medicine, Immunology, Internal Medicine +14

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

L. Jacobsson, Carl Turesson, Anders Gülfe et al. · PubMed · 2005 · 533 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Lenny van Bon, Alsya J. Affandi, Jasper Broen et al. · New England Journal of Medicine · 2013 · 454 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.

Leo A. B. Joosten, M.M. Helsen, Tore Saxne et al. · PubMed · 1999 · 442 citations

Medicine, Immunology, Pharmacology +17

Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden

Johan Askling, C. Michael Fored, Lena Brandt et al. · Arthritis & Rheumatism · 2005 · 415 citations

Medicine, Infectious Diseases, Internal Medicine +14